Your browser doesn't support javascript.
loading
Antineoplastic efficacy profiles of avapritinib and nintedanib in KIT D816V+ systemic mastocytosis: a preclinical study.
Degenfeld-Schonburg, Lina; Gamperl, Susanne; Stefanzl, Gabriele; Schruef, Anna-Katharina; Sadovnik, Irina; Bauer, Karin; Smiljkovic, Dubravka; Eisenwort, Gregor; Peter, Barbara; Greiner, Georg; Hadzijusufovic, Emir; Schwaab, Juliana; Sperr, Wolfgang R; Hoermann, Gregor; Kopanja, Sonja; Szépfalusi, Zsolt; Hoetzenecker, Konrad; Jaksch, Peter; Reiter, Andreas; Arock, Michel; Valent, Peter.
Affiliation
  • Degenfeld-Schonburg L; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna Austria.
  • Gamperl S; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna Austria.
  • Stefanzl G; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna Austria.
  • Schruef AK; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna Austria.
  • Sadovnik I; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna Austria.
  • Bauer K; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna Austria.
  • Smiljkovic D; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna Austria.
  • Eisenwort G; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna Austria.
  • Peter B; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna Austria.
  • Greiner G; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna Austria.
  • Hadzijusufovic E; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna Austria.
  • Schwaab J; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna Austria.
  • Sperr WR; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna Austria.
  • Hoermann G; Ihr Labor, Medical Diagnostic Laboratories Vienna, Austria.
  • Kopanja S; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna Austria.
  • Szépfalusi Z; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna Austria.
  • Hoetzenecker K; Department/Hospital for Companion Animals and Horses, University Hospital for Small Animals, Internal Medicine Small Animals, University of Veterinary Medicine Vienna Austria.
  • Jaksch P; Department of Hematology and Oncology, University Medical Centre Mannheim and Medical Faculty Mannheim, Heidelberg University Germany.
  • Reiter A; Department of Internal Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna Austria.
  • Arock M; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna Austria.
  • Valent P; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna Austria.
Am J Cancer Res ; 13(2): 355-378, 2023.
Article de En | MEDLINE | ID: mdl-36895976
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Am J Cancer Res Année: 2023 Type de document: Article
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Am J Cancer Res Année: 2023 Type de document: Article